Álvarez-Román, M. T.; Cuervo-Arango, I.; Pérez-Santamarina, R.; Poveda, J. L.; Romero, J. A.; Santamaría, A.; Trillo-Mata, J. L.; Tort, M.; Badia, X. Determining the Value Contribution of Emicizumab (Hemlibra®) for the Prophylaxis of Haemophilia A With Inhibitors in Spain by Multi-Criteria Decision Analysis. Grhta 2019, 6.